Human Tumor Markers

Biology and Clinical Applications. Proceedings of the Third International Conference Lacco Ameno d'Ischia, Napoli, Italy, April 23–26, 1986

F. Cimino, G. D. Birkmayer, J. V. Klavins, E. Pimentel, F. Salvatore, F. Cimino, G. D. Birkmayer, J. V. Klavins, E. Pimentel, F. Salvatore

• Publisher: De Gruyter
• Year: 2019
• ISBN:
  9783110846515
• Edition: 1
• Topic: Biological Sciences
• Subtopic: Science General
• Index: Biological Sciences

Table of contents

• PREFACE
• CONTENTS
• OPENING LECTURES
• WHAT DOES "MARKER" MEAN?
• BIOMARKERS AND COLORECTAL CANCER GENETICS: LYNCH SYNDROMES I AND II
• THE HUMAN C-MXB PROTQ-ONCOGENE PRODUCT: IDENTIFICATION AND DETECTION IN IMMATURE LYMPHOID, ERYTHROID, AND MYELOID CELLS
• MOLECULAR BIOLOGY OF TUMOR MARKERS
• UPDATE ON PROTO-ONCOGENES AND HUMAN CANCER
• REGULATION OF THE ADENYLATE CYCLASE ACTIVITY OF CRI4 YEAST MUTANTS BY GTP AND GDP
• RESTRICTION FRAGMENT LENGTH POLYMORPHISMS (RFLPs) AS GENETIC TUMOR MARKERS
• dbl: A NEW TRANSFORMING GENE ISOLATED FROM A HUMAN DIFFUSE B-CELL LYMPHOMA
• DEREGULATED ONCOGENES AS MARKERS FOR MELANOMA FORMATION IN XIPHOPHORUS
• GENE MODULATION BY TUMOR PROMOTERS
• MOLECULAR ANALYSIS OF HTLV-III AND DEVELOPMENT OF DIAGNOTIC AND VACCINE REAGENTS FOR AIDS
• Transforming properties of human cytomegalovirus
• TUMOR ANTIGENS
• GENOMIC MARKERS OF TUMORS
• THE ENIGMA OF A HUMAN TUMOR MARKER: TPA REVISITED
• THE ENIGMA OF A HUMAN TUMOR MARKER: TPA REVISITED
• ALPHA-FETOPROTEIN: ITS DIAGNOSTIC SPECIFICITY AND THERAPEUTIC USE OF ITS ANTIBOBY
• NUCLEOLAR ANTIGENS IN CANCER TISSUES
• POSSIBLE RELATIONSHIP OF MOUSE MAMMARY TUMOR VIRUS (MMTV) TO HUMAN CYTOTROPHOBLAST
• TUMOR ASSOCIATED ANTIGENS FOR INDICATION AND CONTROL OF THERAPY
• TUMOR MARKERS IN THE PATIENT WITH LUNG CANCER
• TPA AND CEA. 7 YEARS OF CLINICAL EXPERIENCE
• BIOCHEMICAL MARKERS IN PANCREATIC CANCER DIAGNOSIS
• FACTORS CONTRIBUTING TO SUPPRESSION OF TUMOUR-HOST RESPONSIVENESS
• ALPHAFETOPROTEIN: THE EPITOME OF CANCER MARKERS
• RESPONSES OF PATIENTS TO THEIR CARCINOMA-ASSOCIATED T AND Tn-SPECIFIC ANTIGENS
• INTERMEDIATE FILAMENTS AND DESMOSOME-ASSOCIATED PROTEINS (DESMOPLAKINS) IN MORPHOLOGIC TUMOR DIAGNOSIS
• IMMUNOCHEMICAL CANCER CHARACTERIZATION
• CHROMOSOMES AS HUMAN TUMOR MARKERS
• IMMUNODIAGNOSIS OF HUMAN CARCINOMAS USING MONOCLONAL ANTIBODIES
• USE OF ANTI-HCG MONOCLONALS IN RIA AND IMMUNOHISTOCHEMISTRY
• MONOCLONAL ANTIBODY DEFINED MARKERS OF HUMAN MELANOMA CELLS
• A MOLECULAR ANALYSIS OF THE CARCINOEMBRYONIC ANTIGEN (CEA) BY MONOCLONAL ANTIBODIES
• MHC STATUS OF PRIMARY HUMAN COLORECTAL CARCINOMA
• ASSESSMENT OF TUMOR ASSOCIATED MONOCLONAL ANTIBODY IN IMMUNOTHERAPY IN SYNGENEIC MODEL
• MODIFIED NUCLEOSIDES
• PSEUDOURIDINE IN BIOLOGICAL FLUIDS OF TUMOR-BEARING PATIENTS
• PSEUDOURIDINE EXCRETION IN EXPERIMENTAL NEOPLASIAS OF RETROVIRAL ORIGIN
• HIGH RESOLUTION QUANTITATIVE RP-HPLC-UV OF NUCLEOSIDES IN RNAs, DNAs, AND mRNAs
• ANALYSIS OF RIBONUCLEOSIDES IN HUMAN BODY FLUIDS AND THEIR POSSIBLE ROLE AS PATHOBIOCHEMICAL MARKERS
• NUCLEOSIDE PROFILES BY HPLC-UV IN SERUM AND URINE OF CONTROLS AND CANCER PATIENTS
• ABERRANT URINARY EXCRETION OF MODIFIED NUCLEOSIDES IN PATIENTS WITH VARIOUS MANIFESTATIONS OF INFECTION WITH HTLV-III/LAV
• MANAGEMENT OF HUMAN LEUKEMIAS
• ACTIVATION OF CELLULAR ONCOGENES FOLLOWING CHROMOSOMAL REARRANGEMENTS AS A POSSIBLE PATHOGENETIC MECHANISM IN HTLV-I POSITIVE AND NEGATIVE T-HELPER-PHENOTYPE CLL
• THERAPEUTIC OPTIONS IN ACUTE LEUKEMIAS
• CHARACTERIZATION OF HUMAN NON-T ACUTE LYMPHOBLASTIC LEUKAEMIA: RESULTS OF A MULTICENTRE STUDY
• HUMAN INTERLEUKIN 1 (ILI) AND INTERLEUKIN 2 (IL2) CAN FUNCTION AS AUTOCRINE GROWTH FACTORS FOR SOME NEOPLASTIC HUMAN LYMPHOID CELLS
• PATIENT SURVEILLANCE
• LONG TERM FOLLOW-UP AND THERAPY MONITORING OF CANCER: IS THE SIMULTANEOUS DOSAGE OF CEA AND TPA USEFUL?
• NEW STRATEGIES FOR FOLLOW UP OF BREAST CANCER PATIENTS USING CEA, TPA, CA 15-3 AND CA 50
• SERUM LIPID SIALIC ACID (LASA) TEST IN DETECTION AND MONITORING OF MALIGNANCIES, PARANEOPLASTIC AND RHEUMATHOID SYNDROMES
• CLINICAL EVALUATION OF NEW TUMOR-ASSOCIATED ANTIGENS
• AN OVERVIEW OF RESULTS. FUTURE PERSPECTIVES OF RADIOIMMUNODETECTION
• TUMOR IMAGING WITH RADIOLABELLED ANTIBODIES
• RECEPTORS AND HORMONES
• HORMONES IN LUNG CANCER
• CLINICAL VALIDATION OF IMMUNORADIOMETRIC ASSAY FOR MEASURING SERUM THYROGLOBULIN IN ANTI-THYROGLOBULIN AUTOANTIBODY POSITIVE SERA IN PATIENTS WITH THYROID CANCER
• ALTERATIONS OF MEMBRANE TSH-RECEPTOR IN THYROID TUMORS
• BINDING OF THE ESTROGEN RECEPTOR TO DEFINED REGIONS OF THE ESTROGEN RESPONSIVE CHICKEN OVALBUMIN GENE AND CONSTRUCTION OF A CONSENSUS SEQUENCE FOR THE DNA SITE WHICH BINDS THE RECEPTOR
• NEW DEVELOPMENTS IN TUMOR MARKERS AND RECEPTORS IN HEAD AND NECK TUfORS
• REGULATION OF HORMONE BINDING OF 17β-ESTRADIOL RECEPTOR BY TYROSINE PHOSPHORYLATION AND PHOSPHOTYROSINE DEPHOSPHORYLATION OF THE RECEPTOR
• ENZYMES AND ISOENZYMES
• SELECTIVE PROTEIN PHOSPHORYLATION BY PROTEIN KINASE C IN CELL ACTIVATION
• PROTEIN KINASE ACTIVITIES OF NORMAL AND TRANSFORMED LYMPHOCYTES
• DEFICIENCY OF 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSPHORYLASE IN HUMAN LEUKEMIA: BIOCHEMICAL ASPECTS AND CLINICAL IMPLICATIONS
• THE ROLE OF MULTIPLE FORMS OF ALKALINE PHOSPHATASE IN CANCER DETECTION AND MONITORING
• GLUTATHIONE TRANSFERASE AS A TUMOR MARKER IN HUMAN BREAST CARCINOMA
• CANCER-RELATED CHANGES IN CREATINE KINASE ISOENZYMES AND VARIANTS
• CLINICAL SIGNIFICANCE OF A REARRANGED HEXOKINASE ISOZYMES EXPRESSION IN NEOPLASTIC PHENOTYPE: THE ASTROCYTOMA MODEL
• ANTIOXYGENIC ENZYMES AS TUMOR MARKERS: A CRITICAL REASSESSMENT OF THE RESPECTIVE ROLES OF SUPEROXIDE DISMUTASE AND GLUTATHIONE PEROXIDASE
• NOVEL ASPECTS OF THE HUMAN ALDOLASE GENE FAMILY AND ITS EXPRESSION IN TUMOR CELLS
• AUTHOR INDEX
• SUBJECT INDEX